Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Allergy Immunotherapy Market is undergoing significant growth and transformation, with the latest industry analysis projecting its value to reach USD 2.69 billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 8.12%. This market's expansion is driven by increased awareness of allergy treatment options and advances in immunotherapy practices. The analysis offers in-depth insights that cater to stakeholders, businesses, investors, and healthcare providers looking to understand the market dynamics and capitalize on emerging opportunities.
Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT), two primary types of immunotherapy, dominate the market segmentation. Each offers unique advantages and continues to evolve with ongoing research. The analysis reveals that SCIT is highly effective for a range of allergies but notes the challenges related to patient compliance. Conversely, SLIT is recognized for its convenience and safety, marking a shift in patient preference towards self-administrated allergy treatment modalities.
Recent Developments and Competitive Landscape
HollisterStier Allergy's recent introduction of Ultrafiltered Dog for the diagnosis and treatment of dog allergies symbolizes the market's innovative stride in January 2023. Similarly, Allergy Partners' collaboration with Aimmune Therapeutics in October 2022 to offer Palforzia, an oral immunotherapy treatment, represents the ongoing evolution and accessibility of allergy treatments. The report also provides a comprehensive overview of competitors, strategic market quadrant positioning, and performance analysis, shedding light on the competitive environment within the industry.
The study covers various geographies, including America, Europe, the Middle East and Africa, and Asia-Pacific, noting the unique market dynamics and consumer preferences in different regions. Highlighting the significance of the Ansoff Analysis and industry SWOT analysis, the report underscores strategic approaches companies can adopt to navigate market expansion, penetration, and diversification.
Comprehensive Market Analysis for Strategic Decision-Making
- Inclusions of in-depth market dynamics, including drivers, restraints, opportunities, and challenges, aid in developing informed strategies.
- Comprehensive market segmentation based on type, application, and distribution channels supports niche targeting.
- Detailed analysis and projections about market size and trends inform long-term planning and competitive edge.
- Regulatory scenarios across multiple geographies assist in ensuring compliance and informed decision-making.
- Extensive analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix provide a holistic view of the industry.
- Insights on major regulatory bodies form an essential part of the strategic planning process.
This report is invaluable for those seeking a detailed and comprehensive understanding of the Allergy Immunotherapy Market's landscape. Market dynamics and competitive analysis are key to identifying business opportunities and driving growth in this thriving market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 188 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $1.82 Billion |
| Forecasted Market Value (USD) by 2028 | $2.69 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
Companies Mentioned
- Aimmune Therapeutics (acquired by Nestlé Health Science)
- ALK-Abelló A/S
- Allergopharma (a subsidiary of Merck Group)
- Anergis SA
- ASIT biotech
- Biomay AG
- Circassia Pharmaceuticals
- CureVac AG
- DBV Technologies
- Genentech (a member of the Roche Group)
- GlaxoSmithKline plc
- HAL Allergy Group
- Inmunotek
- Leti Pharma GmbH
- Merck & Co., Inc.
- Novartis International AG
- Sanofi
- Stallergenes Greer
- Torii Pharmaceutical Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/ilgxwz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
